Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,429,592 papers from all fields of science
Search
Sign In
Create Free Account
imiglucerase
Known as:
imiglucerase [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Narrower (1)
Cerezyme
Drug Allergy
GLUCOSYLCERAMIDASE
Liver diseases
Miglustat
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Długotrwała pancytopenia po chemioterapii jako objaw demaskujący chorobę Gauchera u pacjentki z rakiem płuca
Alicja Markuszewska-Kuczyńska
,
Cecilia Kämpe Björkvall
,
Fryderyk Lorenz
,
G. Kleinotienė
,
Monika Klimkowska
,
M. Machaczka
2014
Corpus ID: 71230055
2013
2013
Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment
N. Weinreb
,
J. Goldblatt
,
+5 authors
C. Hollak
Journal of Inherited Metabolic Disease
2013
Corpus ID: 54522343
ObjectiveWe studied the effect of long-term alglucerase/imiglucerase (Ceredase®/Cerezyme®, Genzyme, a Sanofi company, Cambridge…
Expand
2013
2013
Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study on 34 italian Gaucher type I patients.
L. Deroma
,
A. Sechi
,
+4 authors
B. Bembi
JIMD Reports
2013
Corpus ID: 23736869
Background. Enzyme Replacement Therapy (ERT) is the standard of care in Gaucher disease. The effects of withdrawal or reduced…
Expand
2011
2011
Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply.
A. Zimran
,
G. Altarescu
,
D. Elstein
Blood Cells, Molecules & Diseases
2011
Corpus ID: 24085838
2010
2010
Optimal therapy in Gaucher disease
O. Goker-Alpan
Therapeutics and Clinical Risk Management
2010
Corpus ID: 17281193
Gaucher disease (GD), the inherited deficiency of the lysosomal enzyme glucocerebrosidase, presents with a wide range of symptoms…
Expand
Review
2009
Review
2009
Goal-oriented therapy with miglustat in Gaucher disease.
G. Pastores
,
P. Giraldo
,
P. Cherin
,
A. Mehta
Current Medical Research and Opinion
2009
Corpus ID: 25172524
BACKGROUND Gaucher disease (GD) is a highly heterogeneous disorder with multisystem involvement. Specific therapeutic goals for…
Expand
2004
2004
Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
R. Heitner
,
S. Arndt
,
J. Levin
South African medical journal = Suid-Afrikaanse…
2004
Corpus ID: 35190063
BACKGROUND Gaucher disease is the most common lysosomal storage disorder caused by the insufficiency of the lysosomal enzyme…
Expand
2002
2002
Enzyme replacement therapy with imiglucerase in Taiwanese patients with type I Gaucher disease.
Chia-Chi Hsu
,
Y. Chien
,
M. Lai
,
W. Hwu
Journal of the Formosan Medical Association…
2002
Corpus ID: 34999625
BACKGROUND AND PURPOSE The management of Gaucher disease has been dramatically improved by the development of enzyme replacement…
Expand
2001
2001
Gaucher disease with pulmonary involvement in a 6-year-old girl: report of resolution of radiographic abnormalities on increasing dose of imiglucerase.
S. Y. Lee
,
A. W. Mak
,
K. Huen
,
S. Lam
,
C. Chow
Jornal de Pediatria
2001
Corpus ID: 36536334
We report resolution of ground-glass appearance in high-resolution computed tomography of chest in a 6-year-old girl who had…
Expand
1998
1998
First long-term results of imiglucerase therapy of type 1 Gaucher disease.
C. Niederau
,
S. vom Dahl
,
D. Häussinger
European Journal of Medical Research
1998
Corpus ID: 32329002
BACKGROUND/AIMS In the early 1990s, enzyme replacement therapy with modified placental glucocerebrosidase (alglucerase, Genzyme…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE